Stock 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Equities

002864

CNE1000032C9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
29.16 CNY +0.17% Intraday chart for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd +8.97% -24.24%
Apr. 26 Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023 CI
Apr. 25 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,319 4,047 3,066 -
Enterprise Value (EV) 1 3,319 4,047 3,066 3,066
P/E ratio 33.2 x - - -
Yield - 0.57% 0.69% 0.69%
Capitalization / Revenue - 4.13 x 2.09 x 1.68 x
EV / Revenue - 4.13 x 2.09 x 1.68 x
EV / EBITDA - 24.6 x 14.2 x 11.3 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 2.64 x 2.04 x 1.8 x
Nbr of stocks (in thousands) 85,557 105,155 105,155 -
Reference price 2 38.79 38.49 29.16 29.16
Announcement Date 4/21/23 4/25/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 980.8 1,465 1,824
EBITDA 1 - 164.9 216.1 270.2
EBIT 1 - 134.9 196.2 251.4
Operating Margin - 13.75% 13.39% 13.78%
Earnings before Tax (EBT) - - - -
Net income 101.2 - - -
Net margin - - - -
EPS 1.170 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - 0.2200 0.2000 0.2000
Announcement Date 4/21/23 4/25/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 9.04% 8.87% 10.2%
ROA (Net income/ Total Assets) - - 8.9% 10.2%
Assets - - - -
Book Value Per Share 1 - 14.60 14.30 16.20
Cash Flow per Share 1 - 0.9800 1.480 2.100
Capex 2 - 62.4 10.6 14.4
Capex / Sales - 6.36% 0.72% 0.79%
Announcement Date 4/21/23 4/25/24 - -
1CNY2CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
29.16 CNY
Average target price
41.72 CNY
Spread / Average Target
+43.07%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD Stock Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
-24.24% 424M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.24% 699B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.07% 571B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.64% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 326B
ABBVIE INC. Stock AbbVie Inc.
+3.52% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.68% 236B
NOVARTIS AG Stock Novartis AG
+4.71% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-12.43% 194B
PFIZER, INC. Stock Pfizer, Inc.
-3.73% 154B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002864 Stock
  4. Financials Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd